XML 85 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Re-engineering Costs
 12 Months Ended
Dec. 27, 2014
Restructuring Charges [Abstract]  
Re-engineering Costs
Re-engineering Costs
The Company continually reviews its business models and operating methods for opportunities to increase efficiencies and/or align costs with business performance. Pretax costs incurred in the re-engineering and impairment charges caption by category were as follows:
(In millions)
2014
 
2013
 
2012
Severance
$
7.4

 
$
7.3

 
$
5.3

Other
3.6

 
2.0

 
17.1

Total re-engineering and impairment charges
$
11.0

 
$
9.3

 
$
22.4


The Company recorded re-engineering and impairment charges of $7.4 million, $7.3 million and $5.3 million in 2014, 2013 and 2012, respectively, related to severance costs incurred to reduce headcount in several of its operations in connection with changes in its management and organizational structures, and in 2014, the decision to cease operating the Armand Dupree business in the United States, the Nutrimetics business in Thailand and a manufacturing plant in India, as well as a write-off of $1.1 million in capitalized software in connection with a new information systems project. Re-engineering charges were also related to changes in the Company's European operations in 2013 and exiting the Nutrimetics businesses in Greece and the United Kingdom in 2012. In 2012, re-engineering and impairment charges included $0.9 million in non-severance exit costs, primarily related to the decision to cease operating the Nutrimetics businesses in Greece and the United Kingdom. Also in connection with the liquidation of the Nutrimetics business in the United Kingdom, the Company incurred a $16.2 million non-cash charge that related to the reclassification of currency translation adjustments from accumulated other comprehensive loss into operating income.
Pretax costs incurred in connection with the re-engineering program included above and other amounts allocated to cost of products sold were as follows:
(In millions)
2014
 
2013
 
2012
Re-engineering and impairment charges
$
11.0

 
$
9.3

 
$
22.4

Cost of products sold
2.3

 
—

 
0.2

Total pretax re-engineering costs
$
13.3

 
$
9.3

 
$
22.6


The balances included in accrued liabilities related to re-engineering and impairment charges as of December 27, 2014, December 28, 2013, and December 29, 2012 were as follows:
(In millions)
2014
 
2013
 
2012
Beginning balance
$
2.6

 
$
1.5

 
$
3.0

Provision
11.0

 
9.3

 
22.4

Non-cash charges
(1.8
)
 
(0.1
)
 
(16.2
)
Cash expenditures:
 
 
 
 
 
Severance
(7.1
)
 
(6.1
)
 
(6.0
)
Other
(2.3
)
 
(2.0
)
 
(1.7
)
Ending balance
$
2.4

 
$
2.6

 
$
1.5


The accrual balance as of December 27, 2014, relates primarily to severance payments expected to be made by the end of the second quarter of 2015. In connection with the decision to cease operating the Armand Dupree business in the United States and the Nutrimetics business in Thailand in 2014, the Company recorded charges of $1.9 million and $0.4 million, respectively, in cost of sales for inventory obsolescence. In 2012, the Company recorded $0.2 million of such charges related to the Nutrimetics businesses in Greece and the United Kingdom.